<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="https://blogs.mercola.com:443/utility/FeedStylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><xhtml:meta xmlns:xhtml="http://www.w3.org/1999/xhtml" name="robots" content="noindex" /><title>A Second Patient Victimized by Tysabri</title><link>https://blogs.mercola.com:443/sites/vitalvotes/archive/2005/03/04/a-second-patient-victimized-by-tysabri.aspx</link><description>If you read my blog daily, you know I've been following the shenanigans involving Tysabri this week from the multiple sclerosis (MS) "wonder drug" being pulled from the consumer market due to the death of one patient, to warning signs about the drug that</description><dc:language>en</dc:language><generator>CommunityServer 2008.5 SP1 (Debug Build: 31106.3070)</generator></channel></rss>